Baughman Named to Association’s Nation’s Top One Percent List
The NADC list is extremely exclusive, limited to only the top one percent of lawyers in the country. A blue ribbon panel of attorneys from independent organizations thoroughly vets all prospective members, and then a judicial review board makes the final selection. The mission of the NADC is to recognize attorneys who not only elevate the standards of the Bar, but also provide other attorneys with a benchmark to emulate.
Baughman has represented seven states in cases against the drug maker GlaxoSmithKline regarding the marketing of the diabetes medication Avandia, and has also represented patients and public entities in cases involving harm caused by the kidney dialysis device GranuFlo.
In addition, she formulated litigation strategies in whistleblower cases as managing shareholder of Baron & Budd’s Qui Tam Litigation Group. Her team has handled several cases involving Medicaid and Medicare fraud as well as many others.
Baughman also has a long history of serving the Dallas community. For example, she has provided pro bono representation to clients through the Dallas Volunteer Attorney Program and has also co-chaired several committees for the Attorneys Serving the Community program.
“I cannot overstate how honored I am that an organization as prestigious as the National Association of Distinguished Counsel has named me to this list,” Baughman said. “The Association’s mission is dedicated to holding the legal profession to the highest standards, and I am proud to be recognized in this manner.”
ABOUT BARON & BUDD, P.C.
The law firm of Baron & Budd, P.C., with offices in Dallas, Baton Rouge, New Orleans, Austin and Los Angeles, is a nationally recognized law firm with a nearly 40-year history of "Protecting What’s Right" for people, communities and businesses harmed by negligence. Baron & Budd’s size and resources enable the firm to take on large and complex cases. The firm represents individuals and government and business entities in areas as diverse as dangerous pharmaceuticals and medical devices, environmental contamination, the Gulf oil spill, financial fraud, overtime violations, deceptive advertising, automotive defects, trucking accidents, nursing home abuse, and asbestos-related illnesses such as mesothelioma.